Business Context and Reporting Period
Company: Bovie Medical Corporation (Note: Metadata referenced "Apyx Medical Corp," but the filing text identifies the registrant as Bovie Medical Corporation).
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2010
Business Overview: Bovie Medical Corporation manufactures and markets electrosurgical devices, including generators, accessories, cauteries, and medical lighting. The company operates primarily in the United States and internationally through distributors. During the period, the company consolidated its Canadian facility operations into its Clearwater, Florida facility.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2010 | Nine Months Ended Sep 30, 2010 |
|---|---|---|
| Sales (Revenue) | $6,501,163 | $17,997,180 |
| Gross Profit | $2,703,712 | $7,304,883 |
| Gross Margin | 41.6% | 40.6% |
| Net Income (Loss) | $4,236 | $(165,774) |
| Operating Cash Flow | N/A | $(953,969) |
| Cash and Equivalents (End of Period) | $2,649,410 | $2,649,410 |
| Total Debt (Current + Long Term) | $3,824,325 | $3,824,325 |
Note: Total Debt includes current portion of mortgage ($135,000), mortgage note payable ($3,638,750), equipment loan ($111,575), and amounts due to Lican ($163,400). Line of credit balance was $0.
Material Changes vs. Prior Period
- Revenue Decline: Sales for the nine months ended September 30, 2010, decreased by 11.9% ($2.42 million) compared to the same period in 2009. This was primarily driven by a 16.8% decrease in electrosurgical disposable sales (specifically ablators) and an 11.7% decrease in "Other" products (penlights).
- Profitability Shift: The company reported a net loss of $165,774 for the nine months ended September 30, 2010, compared to a net income of $568,136 in the prior year period. This reversal was largely due to the revenue decline and increased professional fees.
- Operating Expenses: Professional services increased by 20.6% year-over-year, driven by a $134,000 increase in legal fees related to litigation and $55,000 in tax consulting fees for an IRS audit. Conversely, Selling, General, and Administrative (SG&A) expenses decreased by 2.1% due to cost savings from consolidating Canadian operations and the absence of a lawsuit settlement charge incurred in 2009.
- Non-Operating Gains: The company recorded a significant non-cash gain of $799,302 related to the change in fair value of warrant liabilities and amounts due to Lican, which mitigated the operating loss.
Guidance, Outlook, Risks, and Unusual Items
- Capital Raise: In April 2010, the company completed a private placement raising approximately $2.8 million (net of costs) through the issuance of common stock and warrants. This significantly improved liquidity.
- Facility Consolidation: The company consolidated its Windsor, Canada facility into Clearwater, Florida. This resulted in a one-time impairment charge of approximately $67,000 on intangible assets and $175,000 in other consolidation costs.
- Legal Proceedings (Risks):
- Patent Infringement: Salient Surgical Technologies and Medtronic sued the company alleging infringement of a patent related to the SEER fluid-assisted electrosurgical devices. Plaintiffs seek an injunction and unspecified damages. The company intends to vigorously defend.
- Director Litigation: The company filed a complaint against a former director, Steven Livneh, regarding breach of contract and fiduciary duty related to the acquisition of Seal-N-Cut technology.
- Subsequent Event: On November 1, 2010, the company sold its old St. Petersburg facility for $700,000, resulting in a net cash proceeds of $633,000 and a recorded loss of approximately $301,000.
- Liquidity: Management believes cash on hand and anticipated cash flows are sufficient for the next year. The company has an $8 million revolving line of credit (currently $0 utilized) and a $1 million equipment line of credit ($112,000 utilized).
Investor Verification Checklist
- Revenue Concentration: Verify the stability of the top 10 customers, who accounted for 67% of net revenues in the first nine months of 2010.
- Inventory Levels: Review the increase in inventory days sales outstanding to 241 days (from 189 days), indicating a potential slowdown in sales or overstocking of generator parts.
- Legal Exposure: Monitor the status of the Medtronic/Salient patent infringement lawsuit and the lawsuit against the former director, as outcomes could result in significant liabilities or injunctions.
- Warrant Liability: Understand the impact of the $105,000 warrant liability on the balance sheet and the potential for future dilution upon exercise.
- IRS Audit: Confirm the outcome of the IRS examination of the 2008 tax return, which is currently in progress.